Insulin glargine and lixisenatide and Jivi Intravenous
Determining the interaction of Insulin glargine and lixisenatide and Jivi Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: Jivi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Jolessa
- Insulin glargine and lixisenatide-Jolessa extended-cycle
- Insulin glargine and lixisenatide-Jolivette
- Insulin glargine and lixisenatide-Jornay PM
- Insulin glargine and lixisenatide-Juleber
- Insulin glargine and lixisenatide-Juluca
- Jivi Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Jivi Intravenous-Insulin glargine, recombinant Subcutaneous
- Jivi Intravenous-Insulin glulisine
- Jivi Intravenous-Insulin Glulisine (Cartridges and Pens)
- Jivi Intravenous-Insulin Glulisine (Vials)
- Jivi Intravenous-Insulin glulisine Subcutaneous